Ductal or lobular cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Pancreatic Ducts Breast Cell Line, Tumor Nipples Mammary Glands, Animal Pancreas Ductus Arteriosus Epithelial Cells Salivary Ducts Mammary Glands, Human Tumor Cells, Cultured Neoplastic Stem Cells

Organisms2

Mice, Nude Mice, SCID

Diseases44

Carcinoma, Lobular Carcinoma, Ductal, Breast Breast Neoplasms Carcinoma, Ductal Carcinoma, Intraductal, Noninfiltrating Neoplasm Invasiveness Carcinoma in Situ Prostatic Neoplasms Ovarian Neoplasms Lung Neoplasms Neoplasm Metastasis Stomach Neoplasms Colonic Neoplasms Neoplasms Pancreatic Neoplasms Disease Progression Carcinoma Genetic Predisposition to Disease Neoplasm Recurrence, Local Adenocarcinoma Uterine Cervical Neoplasms Precancerous Conditions Cell Transformation, Neoplastic Carcinoma, Squamous Cell Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Adenocarcinoma, Mucinous Rectal Neoplasms Hyperplasia Endometrial Neoplasms Mammary Neoplasms, Experimental Breast Diseases Carcinoma, Acinar Cell Esophageal Neoplasms Liver Neoplasms Neoplasms, Multiple Primary Neoplasms, Second Primary Neovascularization, Pathologic Neoplasms, Radiation-Induced Head and Neck Neoplasms Mouth Neoplasms Neoplasms, Hormone-Dependent Carcinoma, Small Cell

Chemicals and Drugs31

Tumor Markers, Biological Neoplasm Proteins Receptors, Estrogen Receptor, erbB-2 Cancer Vaccines Receptors, Progesterone RNA, Messenger Antineoplastic Agents DNA, Neoplasm Tumor Suppressor Protein p53 RNA, Small Interfering Tamoxifen Prostate-Specific Antigen Antigens, Neoplasm Antineoplastic Agents, Hormonal Ki-67 Antigen Fluorouracil Receptor, Epidermal Growth Factor Antineoplastic Agents, Phytogenic Tumor Suppressor Proteins Cisplatin Anticarcinogenic Agents Antibodies, Monoclonal MicroRNAs Deoxycytidine RNA, Neoplasm Cadherins Estrogen Receptor alpha Estrogens Paclitaxel Proto-Oncogene Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment51

Early Detection of Cancer Prognosis Immunohistochemistry Survival Analysis Survival Rate Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies Neoplasm Staging Mammography Gene Expression Profiling Follow-Up Studies Antineoplastic Combined Chemotherapy Protocols Risk Prospective Studies Xenograft Model Antitumor Assays Registries Risk Assessment Disease-Free Survival Blotting, Western Neoplasm Transplantation Combined Modality Therapy Chemotherapy, Adjuvant Tissue Array Analysis Sensitivity and Specificity Odds Ratio Kaplan-Meier Estimate Neoplasm Grading Oligonucleotide Array Sequence Analysis Transplantation, Heterologous Mastectomy Multivariate Analysis Immunoenzyme Techniques Risk Factors Biopsy, Needle Tumor Burden Mammary Neoplasms, Experimental Mastectomy, Segmental Polymerase Chain Reaction SEER Program Predictive Value of Tests Reproducibility of Results Therapeutic Irrigation Drug Screening Assays, Antitumor Molecular Targeted Therapy Clinical Trials as Topic Treatment Outcome Transfection Questionnaires Biopsy Radiotherapy, Adjuvant Logistic Models

Psychiatry and Psychology1

Phenomena and Processes34

Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Drug Resistance, Neoplasm Mutation Risk DNA Methylation Cell Proliferation Sensitivity and Specificity Odds Ratio Genes, BRCA1 Cell Division Cell Survival Down-Regulation Cell Movement Apoptosis Cell Growth Processes Genotype Genes, Tumor Suppressor Promoter Regions, Genetic Up-Regulation Gene Silencing Cell Cycle Genes, ras Gene Expression Signal Transduction Transfection Genes, Neoplasm Dose-Response Relationship, Drug Polymorphism, Genetic Genes, BRCA2 RNA Interference Genes, p53 Phenotype Germ-Line Mutation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science4

Survival Rate Registries SEER Program Questionnaires

Named Groups1

Health Care23

Survival Analysis Survival Rate Retrospective Studies Follow-Up Studies Risk Prospective Studies Registries National Cancer Institute (U.S.)Risk Assessment Disease-Free Survival Age Factors Sensitivity and Specificity Odds Ratio Kaplan-Meier Estimate Multivariate Analysis Risk Factors SEER Program Predictive Value of Tests Reproducibility of Results Clinical Trials as Topic Treatment Outcome Questionnaires Logistic Models

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Carcinoma, Lobular Carcinoma, Ductal, Breast Breast Neoplasms Carcinoma, Ductal Carcinoma, Intraductal, Noninfiltrating Early Detection of Cancer Pancreatic Ducts Neoplasm Invasiveness Carcinoma in Situ Prostatic Neoplasms Ovarian Neoplasms Lung Neoplasms Gene Expression Regulation, Neoplastic Breast Neoplasm Metastasis Stomach Neoplasms Colonic Neoplasms Tumor Markers, Biological Prognosis Mice, Nude Neoplasm Proteins Receptors, Estrogen Neoplasms Receptor, erbB-2 Pancreatic Neoplasms Immunohistochemistry Disease Progression Cell Line, Tumor Cancer Vaccines Survival Analysis Survival Rate Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies Receptors, Progesterone Neoplasm Staging Carcinoma Nipples Mammography Gene Expression Profiling Follow-Up Studies RNA, Messenger Genetic Predisposition to Disease Neoplasm Recurrence, Local Adenocarcinoma Antineoplastic Agents Uterine Cervical Neoplasms Precancerous Conditions Drug Resistance, Neoplasm Mutation Antineoplastic Combined Chemotherapy Protocols Mammary Glands, Animal Cell Transformation, Neoplastic Carcinoma, Squamous Cell Risk Prospective Studies Xenograft Model Antitumor Assays Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung DNA, Neoplasm Registries National Cancer Institute (U.S.)Pancreas Risk Assessment Tumor Suppressor Protein p53 Colorectal Neoplasms Disease-Free Survival Blotting, Western Neoplasm Transplantation Combined Modality Therapy United States Survivors Age Factors RNA, Small Interfering Chemotherapy, Adjuvant DNA Methylation Ductus Arteriosus Cell Proliferation Adenocarcinoma, Mucinous Tamoxifen Tissue Array Analysis Sensitivity and Specificity Odds Ratio Rectal Neoplasms Epithelial Cells Genes, BRCA1 Hyperplasia Kaplan-Meier Estimate Neoplasm Grading Oligonucleotide Array Sequence Analysis Cell Division Prostate-Specific Antigen Transplantation, Heterologous Mastectomy Multivariate Analysis Immunoenzyme Techniques Antigens, Neoplasm Risk Factors Antineoplastic Agents, Hormonal Cell Survival Salivary Ducts

No FAQ available that match "ductal or lobular cancer"